NCT05607160View on ClinicalTrials.gov

A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

December 11, 2023

Study Completion Date

December 11, 2023

Conditions
Type 2 Diabetes Mellitus (T2DM)
Trial Locations (1)

Unknown

Investigational site, Germany

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY